Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
85.4M
-
Number of holders
-
127
-
Total 13F shares, excl. options
-
57.8M
-
Shares change
-
-875K
-
Total reported value, excl. options
-
$278M
-
Value change
-
-$5.11M
-
Put/Call ratio
-
0.06
-
Number of buys
-
79
-
Number of sells
-
-39
-
Price
-
$4.81
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q4 2022
148 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q4 2022.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.8M shares
of 85.4M outstanding shares and own 67.72% of the company stock.
Largest 10 shareholders include FMR LLC (11.7M shares), BlackRock Inc. (8.03M shares), EcoR1 Capital, LLC (6.18M shares), VANGUARD GROUP INC (6.09M shares), FEDERATED HERMES, INC. (3.08M shares), Bain Capital Life Sciences Investors, LLC (2.49M shares), STATE STREET CORP (1.94M shares), Cormorant Asset Management, LP (1.55M shares), GEODE CAPITAL MANAGEMENT, LLC (1.44M shares), and Tyrus Capital S.A.M. (1.26M shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.